TY - JOUR
T1 - Asymmetric drug binding in an ATP-loaded inward-facing state of an ABC transporter
AU - Thaker, Tarjani M.
AU - Mishra, Smriti
AU - Zhou, Wenchang
AU - Mohan, Michael
AU - Tang, Qingyu
AU - Faraldo-Goméz, José D.
AU - Mchaourab, Hassane S.
AU - Tomasiak, Thomas M.
N1 - Funding Information:
This research was funded by the Division of Intramural Research of the National Heart, Lung and Blood Institute (W.Z. and J.D.F.G.), and grants from the National Institute of General Medicine Sciences and National Institute of Allergy and Infectious Disease awarded to T.M.T. (grant nos. R00 GM114245 and R01 AI156270) and H.S.M. (grant no. R01 GM128087). Computational resources were in part provided by the National Institutes of Health (NIH) HPC facility Biowulf. A portion of this research was supported by NIH grant no. U24GM129547 and performed at the PNCC at the Oregon Health Sciences University and accessed through Environmental Molecular Sciences Laboratory (grid.436923.9), a Department of Energy Office of Science User Facility sponsored by the Office of Biological and Environmental Research. We thank T. Humphries and other support staff at the PNCC for assistance with cryo-EM data collection. We thank D. Williams with assistance with cryo-EM data collection and resources supported by National Science Foundation funding (grant no. NSF1531991) awarded to the Eyring Materials Center at Arizona State University. This work was also supported by resources in the University of Arizona Imaging Cores – Life Sciences North (grant no. S10 OD011981). We thank members of the Tomasiak laboratory and D. Claxton from the Mchaourab laboratory for critical reading of this paper.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2022/2
Y1 - 2022/2
N2 - Substrate efflux by ATP-binding cassette (ABC) transporters, which play a major role in multidrug resistance, entails the ATP-powered interconversion between transporter intermediates. Despite recent progress in structure elucidation, a number of intermediates have yet to be visualized and mechanistically interpreted. Here, we combine cryogenic-electron microscopy (cryo-EM), double electron–electron resonance spectroscopy and molecular dynamics simulations to profile a previously unobserved intermediate of BmrCD, a heterodimeric multidrug ABC exporter from Bacillus subtilis. In our cryo-EM structure, ATP-bound BmrCD adopts an inward-facing architecture featuring two molecules of the substrate Hoechst-33342 in a striking asymmetric head-to-tail arrangement. Deletion of the extracellular domain capping the substrate-binding chamber or mutation of Hoechst-coordinating residues abrogates cooperative stimulation of ATP hydrolysis. Together, our findings support a mechanistic role for symmetry mismatch between the nucleotide binding and the transmembrane domains in the conformational cycle of ABC transporters and is of notable importance for rational design of molecules for targeted ABC transporter inhibition. [Figure not available: see fulltext.].
AB - Substrate efflux by ATP-binding cassette (ABC) transporters, which play a major role in multidrug resistance, entails the ATP-powered interconversion between transporter intermediates. Despite recent progress in structure elucidation, a number of intermediates have yet to be visualized and mechanistically interpreted. Here, we combine cryogenic-electron microscopy (cryo-EM), double electron–electron resonance spectroscopy and molecular dynamics simulations to profile a previously unobserved intermediate of BmrCD, a heterodimeric multidrug ABC exporter from Bacillus subtilis. In our cryo-EM structure, ATP-bound BmrCD adopts an inward-facing architecture featuring two molecules of the substrate Hoechst-33342 in a striking asymmetric head-to-tail arrangement. Deletion of the extracellular domain capping the substrate-binding chamber or mutation of Hoechst-coordinating residues abrogates cooperative stimulation of ATP hydrolysis. Together, our findings support a mechanistic role for symmetry mismatch between the nucleotide binding and the transmembrane domains in the conformational cycle of ABC transporters and is of notable importance for rational design of molecules for targeted ABC transporter inhibition. [Figure not available: see fulltext.].
UR - http://www.scopus.com/inward/record.url?scp=85121487179&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85121487179&partnerID=8YFLogxK
U2 - 10.1038/s41589-021-00936-x
DO - 10.1038/s41589-021-00936-x
M3 - Article
C2 - 34931066
AN - SCOPUS:85121487179
SN - 1552-4450
VL - 18
SP - 226
EP - 235
JO - Nature Chemical Biology
JF - Nature Chemical Biology
IS - 2
ER -